Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Trial of Two Standard Dose Fractionation Regimes for Adjuvant Vaginal Brachytherapy in Early Stage Endometrial Cancer

NCT03785288 is registered in ClinicalTrials.gov with Kara Romano, MD as lead sponsor.

NCT NCT03785288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03785288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Trial of Two Standard Dose Fractionation Regimes for Adjuvant Vaginal Brachytherapy in Early Stage Endometrial Cancer
Lead sponsor
Kara Romano, MD
Phase
Phase 3
Overall status
Recruiting
Start date
January 17, 2019
Completion date
January 30, 2028
Enrollment
258 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer